Galmed Pharmaceuticals (GLMD) Institutional Ownership → “The Biggest Bubble of All Time” – Here’s What to Do. (From Chaikin Analytics) (Ad) Free GLMD Stock Alerts $0.38 -0.02 (-5.63%) (As of 11:04 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$6.17M Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)Get the free details now. Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022 Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% 11/16/2021Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/16/2021Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% 11/2/2021 Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021 Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% 8/5/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868% 7/31/2021Brave Asset Management Inc.11,470$35K0.0%N/A0.046% 5/19/2021Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219% 5/17/2021Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105% 5/14/2021Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838% 5/13/2021Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242% 3/26/2021Susquehanna International Group LLP10,483$33K0.0%N/A0.042% 2/16/2021Squarepoint Ops LLC21,010$65K0.0%-12.5%0.100% 2/16/2021Baker BROS. Advisors LP184,927$575K0.0%-10.0%0.876% 2/10/2021Renaissance Technologies LLC115,800$360K0.0%+238.2%0.548% 2/3/2021Ibex Investors LLC1,525,000$4.74M1.9%+0.7%7.223% 11/16/2020Squarepoint Ops LLC24,024$85K0.0%N/A0.114% 11/13/2020Morgan Stanley130,165$459K0.0%+17.6%0.617% 11/12/2020Voss Capital LLC125,000$443K0.3%-6.6%0.592% 11/10/2020Phoenix Holdings Ltd.145,865$480K0.0%+8.5%0.691% 11/9/2020P.A.W. Capital Corp200,000$706K0.8%+100.0%0.947% 11/4/2020 Raymond James & Associates228,569$807K0.0%-57.2%1.083% 11/3/2020Ibex Investors LLC1,515,000$5.35M2.8%+53.8%7.176% 10/20/2020Wedbush Securities Inc.13,003$46K0.0%N/A0.062% 8/14/2020Nantahala Capital Management LLC2,072,745$9.91M0.3%+59.0%9.817% 8/14/2020BVF Inc. IL1,799,694$8.60M0.5%-1.8%8.524% 8/12/2020Ibex Investors LLC985,000$4.71M2.2%+2.1%4.665% 7/28/2020 Raymond James & Associates534,609$2.56M0.0%+55.3%2.532% 5/20/2020Phoenix Holdings Ltd.75,383$253K0.0%+312.9%0.357% 5/18/2020 Vivo Capital LLC860,103$2.98M0.3%N/A4.069% 5/15/2020Squarepoint Ops LLC34,350$119K0.0%+238.9%0.162% 5/15/2020Voss Capital LLC159,454$319K0.4%+5.9%0.754% Wall Street Legend Issues New NVDA Warning (Ad)Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.Click here for the stock details5/15/2020Morgan Stanley77,552$269K0.0%+24.6%0.367% 5/15/2020Two Sigma Securities LLC16,330$57K0.0%N/A0.077% 5/14/2020Ibex Investors LLC965,000$3.34M3.4%+1.0%4.565% 5/14/2020ETF Managers Group LLC41,548$143K0.0%+9.8%0.197% 4/21/2020 Raymond James & Associates344,195$1.19M0.0%-14.7%1.628% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), Western Wealth Management LLC ($38K).Learn more on GLMD's institutional investors. What percentage of Galmed Pharmaceuticals stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which institutional investors have been buying Galmed Pharmaceuticals stock? The following institutional investors have purchased Galmed Pharmaceuticals stock in the last 24 months: Western Wealth Management LLC ($59.07K). How much institutional buying is happening at Galmed Pharmaceuticals? Institutional investors have bought a total of 59,074 shares in the last 24 months. This purchase volume represents approximately $575.97K in transactions. Which Galmed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M). How much institutional selling is happening at Galmed Pharmaceuticals? Institutional investors have sold a total of 1,649,817 shares in the last 24 months. This volume of shares sold represents approximately $6.17M in transactions. Related Companies: PRFX Institutional Ownership LSDI Institutional Ownership QLGN Institutional Ownership INM Institutional Ownership CMND Institutional Ownership ATNF Institutional Ownership NBSE Institutional Ownership SLRX Institutional Ownership NTBL Institutional Ownership PBLA Institutional Ownership This page (NASDAQ:GLMD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
